These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5063496)

  • 1. Exfoliative cytology and chromosomal analysis in tumor of the bladder by pumping method.
    Nagayama T; Kataumi S
    Hinyokika Kiyo; 1972 Jan; 18(1):5-11. PubMed ID: 5063496
    [No Abstract]   [Full Text] [Related]  

  • 2. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
    Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of malignant bladder mucosa using autoradiography of exfoliated epithelial cells.
    Weber MM
    Acta Cytol; 1969 Mar; 13(3):128-32. PubMed ID: 5253720
    [No Abstract]   [Full Text] [Related]  

  • 4. Exfoliative cytology of the urine in tumour diagnosis.
    Puntala P; Koivuniemi A; Sivula A
    Ann Chir Gynaecol Fenn; 1969; 58(1):20-3. PubMed ID: 5392146
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic cytology in the clinical aspects of bladder and breast neoplasms].
    Rasà G
    G Ital Chir; 1966 Jul; 22(4):447-73. PubMed ID: 5984318
    [No Abstract]   [Full Text] [Related]  

  • 8. Exfoliative cytology of metastatic cancer in lung.
    Burke MD; Melamed MR
    Acta Cytol; 1968; 12(1):61-74. PubMed ID: 5239749
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
    Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FISHing and beyond in urinary cytology.
    Dahmoush L; Cohen MB
    Diagn Cytopathol; 2004 Oct; 31(4):201. PubMed ID: 15386797
    [No Abstract]   [Full Text] [Related]  

  • 12. Bladder cancer detection using FISH (UroVysion assay).
    Halling KC; Kipp BR
    Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer of the bladder with revealing cytological smear 7 years before the appearance of the tumor].
    Benassayag E; Galian P; Nuovo V
    J Urol Nephrol (Paris); 1975 Jun; 81(6):466-8. PubMed ID: 1152141
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM; Kiemeney LA; Witjes JA
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current status of bladder cancer.
    Murphy GP
    Surg Annu; 1975; 7():175-218. PubMed ID: 1101401
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exfoliative cytology of urinary tract tumor].
    Ochiai K; Inada T
    Nihon Rinsho; 1966 Oct; 24(10):1938-42. PubMed ID: 6007340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.